Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Sales, Inc.
Orest Olejnik
Edward D. S. Kerslake
Allergan Sales, Llc
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=32963036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2474280(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Sales, Inc., Orest Olejnik, Edward D. S. Kerslake, Allergan Sales, Llc, Allergan, Inc.filedCriticalAllergan Sales, Inc.
Priority claimed from CA002402405Aexternal-prioritypatent/CA2402405C/en
Publication of CA2474280A1publicationCriticalpatent/CA2474280A1/en
Application grantedgrantedCritical
Publication of CA2474280CpublicationCriticalpatent/CA2474280C/en
Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier compo-nents, alpha-2-adrenergcic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. Tn one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists In an-other embodiment, the solubility enhancing components include carhoxymethylcellulose.